Women's Cancer Initiative publishes annual report

19 January 2016

A campaign to improve the prevention of women’s cancers in Latin America and the Caribbean has marked its first anniversary by launching its annual report.

The Women’s Cancer Initiative in the Americasis is run by the Pan American Health Organization (PAHO) Foundation, with support from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and its members, with additional contributions from Bristol-Myers Squibb and Pfizer.

The three-year project aims to improve the effectiveness of breast and cervical cancer programs in at least two Latin American/Caribbean countries and improve the quality and effectiveness of cancer registries in at least four.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >